Posted On: 06/05/2014 2:33:00 PM
Post# of 30067
Posted today on Ihub from a poster.
well the only real milestone is the Lympro test. If they can JV with that then the stock goes up. In his last taped address, GC stopped himself when noting that the negotiations were close. I listened to it and then posted it.
He did say LATE second half before revenue in Lympro. He said first patient with eltoprazine before the end of the year. he did say 15-18 months before MANF.
So, there are not that many milestones on the agenda. The price of Lympro says that it will only be used for research initially. ( 1000-1500 )
So, the prediction is generally up, but not that high with catalysts in July, and towards the end of the year, that we know about so far.
GC's tweet last night.
Gerald Commissiong @G_Commish · 17h
@fazoinnorcal Nothing new came today. Getting all of our ducks in a row on MANF, LymPro and Elto. AAIC and functional MANF data are on deck
Seems the poster doesn't like to keep up with current events.
well the only real milestone is the Lympro test. If they can JV with that then the stock goes up. In his last taped address, GC stopped himself when noting that the negotiations were close. I listened to it and then posted it.
He did say LATE second half before revenue in Lympro. He said first patient with eltoprazine before the end of the year. he did say 15-18 months before MANF.
So, there are not that many milestones on the agenda. The price of Lympro says that it will only be used for research initially. ( 1000-1500 )
So, the prediction is generally up, but not that high with catalysts in July, and towards the end of the year, that we know about so far.
GC's tweet last night.
Gerald Commissiong @G_Commish · 17h
@fazoinnorcal Nothing new came today. Getting all of our ducks in a row on MANF, LymPro and Elto. AAIC and functional MANF data are on deck
Seems the poster doesn't like to keep up with current events.
(0)
(0)
